PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 48 filers reported holding PAIN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $33,000 | -93.2% | 58,411 | -88.0% | 0.00% | -96.2% |
| Q3 2016 | $485,000 | -58.5% | 485,369 | -9.0% | 0.05% | -72.0% |
| Q2 2016 | $1,168,000 | +14.6% | 533,126 | +16.6% | 0.19% | +2.2% |
| Q1 2016 | $1,019,000 | +34.8% | 457,128 | +5.8% | 0.18% | +75.0% |
| Q4 2015 | $756,000 | -4.4% | 432,128 | 0.0% | 0.10% | -10.3% |
| Q3 2015 | $791,000 | +5.7% | 432,128 | 0.0% | 0.12% | -25.2% |
| Q2 2015 | $748,000 | +185.5% | 432,128 | +212.0% | 0.16% | +55.0% |
| Q1 2015 | $262,000 | -6.8% | 138,502 | 0.0% | 0.10% | -18.7% |
| Q4 2014 | $281,000 | -68.1% | 138,502 | -13.4% | 0.12% | -64.1% |
| Q1 2014 | $880,000 | -57.6% | 160,000 | -62.5% | 0.34% | -42.2% |
| Q4 2013 | $2,076,000 | +52.6% | 427,071 | -14.6% | 0.59% | +71.9% |
| Q3 2013 | $1,360,000 | +23.1% | 500,000 | 0.0% | 0.34% | -6.5% |
| Q2 2013 | $1,105,000 | – | 500,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |